{"id":128509,"name":"KANEKA PHARMA AMERICA, LLC","slug":"kaneka-pharma-america-llc","state":"CA","description":"Distributor of life science systems","totalSpending":1210000,"filings":26,"yearlySpending":[{"year":2018,"income":250000},{"year":2019,"income":180000},{"year":2020,"income":220000},{"year":2021,"income":190000},{"year":2022,"income":140000},{"year":2024,"income":120000},{"year":2025,"income":110000}],"firms":["KING & SPALDING LLP"],"lobbyists":["ALLISON KASSIR","PREEYA PINTO","DAVID FARBER","WILLIAM CLARKSON","JEANNINE BENDER","MICHAEL ANDREWS","ALEXANDER (\"ANDER\") CRENSHAW","SCOTT DZIENGELSKI"],"issues":["MMM"],"sampleDescriptions":["Advocacy in support of Medicare coverage for Dialysis-Related Amyloidosis (DRA) Treatment","Advocacy in support of Medicare coverage for Dialysis-Related Amyloidosis (DRA) Treatment.","Advocacy in support of Medicare coverage for Dialysis-Related Amyloidosis (DRA) Treatment; H.R. 8999.","Advocacy in support of Medicare Coverage for Dialysis-Related Amyloidosis (DRA) Treatment. H.R. 8999 (118th Cong.).","Advocacy in support of Medicare Coverage for Dialysis-Related Amyloidosis (DRA) Treatment. H.R. 4055 (119th Cong.)."],"years":[2018,2019,2020,2021,2022,2024,2025]}